Medite Cancer Diagnostics (MDIT) Starts Presentation at LD Micro Main Event
Medite Cancer Diagnostics (OTC: MDIT) is a medical technology company that engages in the development, engineering, manufacture and marketing of medical devices and consumables for the detection, risk assessment, and diagnosis of cancer and related diseases. The company offers USE33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC15 Duo or Trio; TES99; TES Valida; M530; A550; M380; TST44; COT20 linear staining systems; and RCM9000, ACS720, and TWISTER glass and robotic coverslippers. For more information, visit the company's website at www.medite-group.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…







